HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors. - Wikidata - awgldk - TriplyDB

HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors.

HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors.

http://www.wikidata.org/entity/Q37069841

about

Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Nanoparticle-based targeted therapeutics in head-and-neck cancer Recent progress in the development of polysaccharide conjugates of docetaxel and paclitaxel Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy Targeted Nanodelivery of Drugs and Diagnostics Endosomal trafficking of nanoformulated antiretroviral therapy facilitates drug particle carriage and HIV clearance.Nanomedical engineering: shaping future nanomedicines.A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors.Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles.Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs Redox-sensitive nanoparticles from amphiphilic cholesterol-based block copolymers for enhanced tumor intracellular release of doxorubicin.Targeted polymeric therapeutic nanoparticles: design, development and clinical translation Expression of folate receptors in nasopharyngeal and laryngeal carcinoma and folate receptor-mediated endocytosis by molecular targeted nanomedicine Small-molecule delivery by nanoparticles for anticancer therapy A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model.Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer Paclitaxel Nano-Delivery Systems: A Comprehensive Review.Nanotechnology and drug delivery: an update in oncology.Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors.Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.Glucan particles for macrophage targeted delivery of nanoparticles.An unusual role of folate in the self-assembly of heparin-folate conjugates into nanoparticles.In vivo photoacoustic molecular imaging of breast carcinoma with folate receptor-targeted indocyanine green nanoprobes.A complementary strategy for enhancement of nanoparticle intracellular uptake.Folate-mediated chemotherapy and diagnostics: An updated review and outlook.Microfluidic approach for highly efficient synthesis of heparin-based bioconjugates for drug delivery.Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles.Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma.WebPK, a web-based tool for custom pharmacokinetic simulation.Co-delivery of paclitaxel and cetuximab by nanodiamond enhances mitotic catastrophe and tumor inhibition.Phenylboronic Acid-Mediated Tumor Targeting of Chitosan Nanoparticles.Inhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles.Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy.Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.

P2860

Q26830028-CA3DC53D-57A8-4D3D-A70E-A076F52278A7 Q26999699-363793F0-832D-408C-9F02-F5EBE817A790 Q27010654-C90930DC-CFB9-49CC-8FFC-D3E2A3B3BCD4 Q28540108-1957DB3D-DE60-4D30-8024-ECD53FB24E69 Q28551873-77A7635D-7FE2-4B25-AD79-FBB9475567F1 Q33900258-40ACFB7A-0AC3-49C4-9985-C4BD29F7AA72 Q34059457-EC1EC66B-B570-4E21-A716-EF6A5AB55BA0 Q35019550-3824A6E9-9388-4218-BC03-6563E7854B03 Q35232504-9C1BB138-C871-4402-8D3D-387EC0D4CACB Q35703450-321A2522-7CFE-4004-BF56-42CB53971646 Q35911710-DC97A0F2-ACA4-495C-8884-D313CB73A75D Q35979166-030AA8C8-A0A4-4F23-AC54-36C8073C3761 Q36096040-43B79D5B-680B-43E8-8BA4-86357D4ABB92 Q36236817-D833A3FC-D408-4651-A7B1-8F4DBA7043D6 Q36934007-D6F840E0-D1F3-478E-BCE8-7F1BA4E1B335 Q37014465-45781E14-A747-4B8D-9C36-AF1DB21DB136 Q37059874-E5698A11-9C41-4747-A8C4-3C4A45B45F1C Q37172880-A3D45F17-5965-4DE5-9DD2-23EEA7871CA6 Q37188867-2D903072-8838-4D44-A16F-66C39596BC9D Q37225532-F575A3A9-32BC-4A0E-BC49-AE230BBED600 Q37250009-4DD2B347-62F9-4607-8C63-BA171ECA0F86 Q37394893-43F66FFE-440F-4A31-B143-7B32CDE3D7F6 Q37525035-99FC98E6-B266-4A71-9E9F-7B1D4AD9A283 Q37609544-CF8AD84F-17E0-4883-88CB-A31344CB7E0A Q38055067-F4A97A03-A024-412D-A6F2-B2035F219B51 Q38067265-E5250012-675E-491A-ABDA-670752E8BD8F Q38730668-DA5CC71E-34EE-48C7-9043-A2E67D500047 Q38840381-44EDD373-4456-408C-B1A1-7E4E3F0FA0FC Q38947267-E09CB29F-511F-4024-AC51-9C4651BA1889 Q39021925-B96A6296-8D5E-41DE-9202-B4BB01CEE504 Q39149880-C5E76B26-AD9A-4442-A10A-F02C70AFD615 Q39434344-65B70DB5-BF31-4D37-BBC3-92817AAD32A3 Q39451814-546F4364-3775-4764-B990-67413CF83DE7 Q39664427-7F3D8C50-0900-48F9-846B-E9EE85AA491D Q40965484-299495B9-181A-4558-BE51-1BBF5D707247 Q41550469-F555B3CD-4DE6-4F70-B74E-7896B2D8F1FB Q42126409-BB63970D-7D80-4513-97AF-129AD01093BA Q43098728-FDD688B3-5A18-407A-9013-CF2061E73138 Q47621457-49263252-3B1E-49EF-B26B-62E0C0221754 Q47694519-E525571E-3500-4DDE-A42C-7CEA87DAC703

P2860

HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors.

http://www.wikidata.org/entity/Q37069841

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HFT-T, a targeting nanoparticl ...... late receptor-positive tumors.

@en

HFT-T, a targeting nanoparticl ...... late receptor-positive tumors.

@nl

type

label

HFT-T, a targeting nanoparticl ...... late receptor-positive tumors.

@en

HFT-T, a targeting nanoparticl ...... late receptor-positive tumors.

@nl

prefLabel

HFT-T, a targeting nanoparticl ...... late receptor-positive tumors.

@en

HFT-T, a targeting nanoparticl ...... late receptor-positive tumors.

@nl

P1433

Q37069841-003A284E-EC43-47AF-8522-BBB414974262

P1476

Q37069841-E283E793-6437-43BF-9BD0-CF3FF01A858E

P2093

Q37069841-2DA16B1B-1E17-4498-995A-BCD6C21C4160

Q37069841-49886759-3B1B-4881-A4F4-8F35930D0183

Q37069841-5AB1F33A-44FB-4B35-A007-925ED91F2738

Q37069841-5C33B3CC-6949-46FB-8BA4-D5A408C01861

Q37069841-5D53B426-9CF6-4AA7-8A68-BE1926B0A432

Q37069841-6884697E-1EC7-4A3B-B415-451F559DE577

Q37069841-6F16D98D-BD88-4BE8-999A-734BC71B7F59

Q37069841-827DF2C5-CC16-4FD9-B506-01EA6D9A9DD2

Q37069841-9129193E-1877-4E5C-8743-411507FCE1E2

Q37069841-98A096DD-DEB0-485B-AA4A-7FB8A9745B0F

P2860

Q37069841-0C61145E-4A60-41F1-B945-F7DE88347EEB

Q37069841-0CD531D1-4893-4E6B-BA60-F0C31DBAFD52

Q37069841-0F14CE76-722C-428A-940E-5EDB219C47CC

Q37069841-1C7C923E-9EFF-4E77-99E2-594E5204F4DE

Q37069841-22D4F269-043D-45AF-9241-3CE56B1C3DAC

Q37069841-37B71E28-9FE8-4DCA-AF94-89FE60B08BE4

Q37069841-3BDB835A-A07D-43C7-BDF9-97ABC3417C60

Q37069841-3CDFDD6A-0D48-40E7-A576-7E6BBCF01A4C

Q37069841-43A81C08-EBF3-4712-95BB-EFFB2379B91D

Q37069841-4666C9DC-9580-438E-8686-1F66352FD2FB

P304

Q37069841-8F13A903-FA9C-41E1-BEC3-4207707E0E41

P31

Q37069841-A694E695-C506-471C-8346-7403CE610924

P356

Q37069841-A4BE3757-7721-4FB5-B27C-C5EFCA735ED3

P407

Q37069841-DFF541F0-BD8F-4732-9280-A32D61D08650

P433

Q37069841-2729220B-0625-444B-869F-0C7C36171536

P478

Q37069841-81FFC7D9-824E-455A-A169-0FFAF7F4ACC5

P50

Q37069841-8633847E-3BA9-46DC-9E6F-CA6E13ED99AB

P577

Q37069841-22AB6F00-3022-46DA-8A00-7B0619DE81DD

P698

Q37069841-3C5375DD-C828-4275-BC4C-CFEC146E42D5

P921

Q37069841-00B0395E-CA98-4C03-9261-96FABB928232

P932

Q37069841-838C98F1-0544-45F4-A20D-6DF6A78BD27D

P356

P1433

P1476

HFT-T, a targeting nanoparticl ...... olate receptor-positive tumors

@en

P2093

Ada Gjyrezi

http://www.w3.org/2001/XMLSchema#string

Dong M Shin

http://www.w3.org/2001/XMLSchema#string

Gloria Kim

http://www.w3.org/2001/XMLSchema#string

Hyung Ju C Shin

http://www.w3.org/2001/XMLSchema#string

Jun Li

http://www.w3.org/2001/XMLSchema#string

Kwang Jae Cho

http://www.w3.org/2001/XMLSchema#string

Lydia Koenig

http://www.w3.org/2001/XMLSchema#string

Mourad Tighiouart

http://www.w3.org/2001/XMLSchema#string

Shuming Nie

http://www.w3.org/2001/XMLSchema#string

Xu Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

Therapeutic nanoparticles for drug delivery in cancer

Nanoparticle therapeutics: an emerging treatment modality for cancer

Modification of cyclosporin A and conjugation of its derivative to HPMA copolymers.

Phase I trial of taxol in patients with advanced cancer.

Targeted drug delivery via the folate receptor.

Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma.

Poly(L-glutamic acid)--anticancer drug conjugates.

Novel approaches for targeted cancer therapy.

Nanoparticle and targeted systems for cancer therapy.

P304

3165-3174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/NN900649V

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Paraskevi Giannakakou

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19761191

http://www.w3.org/2001/XMLSchema#string

P921

P932

3733355

http://www.w3.org/2001/XMLSchema#string